Emergence in southern France of a new SARS-CoV-2 variant harbouring both N501Y and E484K substitutions in the spike protein.


Journal

Archives of virology
ISSN: 1432-8798
Titre abrégé: Arch Virol
Pays: Austria
ID NLM: 7506870

Informations de publication

Date de publication:
Apr 2022
Historique:
received: 21 12 2021
accepted: 24 01 2022
pubmed: 19 2 2022
medline: 1 4 2022
entrez: 18 2 2022
Statut: ppublish

Résumé

SARS-CoV-2 variants have become a major virological, epidemiological, and clinical concern, particularly with regard to the risk of escape from vaccine-induced immunity. Here, we describe the emergence of a new variant, with the index case returning from travel in Cameroon. For 13 SARS-CoV-2-positive patients living in the same geographical area of southeastern France, a qPCR test for screening variant-associated mutations showed an atypical combination. The genome sequences were obtained by next-generation sequencing with Oxford Nanopore Technologies on GridION instruments within about 8 h. Analysis revealed 46 nucleotide substitutions and 37 deletions, resulting in 30 amino acid substitutions and 12 deletions. Fourteen of the amino acid substitutions, including N501Y and E484K, and nine deletions are located in the spike protein. This genotype pattern led to the establishment of a new Pangolin lineage, named B.1.640.2, that is a phylogenetic sister group to the old B.1.640 lineage, which has now been renamed B.1.640.1. The lineages differ by 25 nucleotide substitutions and 33 deletions. The combination of mutations in these isolates and their phylogenetic position indicate, based on our previous definition, that they represent a new variant, which we have named "IHU". These data are a further example of the unpredictability of the emergence of SARS-CoV-2 variants, and of their possible introduction into a given geographical area from abroad.

Identifiants

pubmed: 35178586
doi: 10.1007/s00705-022-05385-y
pii: 10.1007/s00705-022-05385-y
pmc: PMC8853869
doi:

Substances chimiques

Spike Glycoprotein, Coronavirus 0
spike protein, SARS-CoV-2 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1185-1190

Subventions

Organisme : Agence Nationale de la Recherche
ID : Méditerranée-Infection 10-IAHU-03
Organisme : Région Provence Alpes Côte d'Azur and Europe
ID : FEDER PA 0000320 PRIMMI

Informations de copyright

© 2022. The Author(s).

Références

Nat Rev Microbiol. 2021 Jul;19(7):409-424
pubmed: 34075212
Bioinformatics. 2018 Dec 1;34(23):4121-4123
pubmed: 29790939
Science. 2021 Oct 22;374(6566):472-478
pubmed: 34554826
Euro Surveill. 2020 Aug;25(32):
pubmed: 32794443
Lancet Infect Dis. 2022 Feb;22(2):152-153
pubmed: 34756187
Eur J Clin Microbiol Infect Dis. 2020 Aug;39(8):1601-1603
pubmed: 32270412
Lancet. 2021 Dec 11;398(10317):2126-2128
pubmed: 34871545
Front Microbiol. 2022 Feb 07;12:786233
pubmed: 35197938
Nat Microbiol. 2020 Nov;5(11):1403-1407
pubmed: 32669681
New Sci. 2021 Nov 27;252(3362):8
pubmed: 34866732
Proc Natl Acad Sci U S A. 2021 Mar 2;118(9):
pubmed: 33579792
J Infect. 2021 Aug;83(2):197-206
pubmed: 34089757
Nat Rev Genet. 2021 Dec;22(12):757-773
pubmed: 34535792
Viruses. 2021 Oct 28;13(11):
pubmed: 34834983
J Clin Virol. 2021 Jul;140:104868
pubmed: 34029990
Acta Biomed. 2020 Mar 19;91(1):157-160
pubmed: 32191675
Eur J Clin Microbiol Infect Dis. 2021 Mar;40(3):477-484
pubmed: 33389257
Bioinformatics. 2018 Sep 15;34(18):3094-3100
pubmed: 29750242

Auteurs

Philippe Colson (P)

IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13005, Marseille, France.
Institut de Recherche pour le Développement (IRD), Microbes Evolution Phylogeny and Infections (MEPHI), Aix-Marseille Université, 27 boulevard Jean Moulin, 13005, Marseille, France.
Assistance Publique-Hôpitaux de Marseille (AP-HM), 264 rue Saint-Pierre, 13005, Marseille, France.

Jérémy Delerce (J)

IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13005, Marseille, France.

Emilie Burel (E)

IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13005, Marseille, France.

Jordan Dahan (J)

Laboratoire de Biologie Médicale, Synlab Provence Marseille, 25 rue Rabattu, 13015, Marseille, France.

Agnès Jouffret (A)

Laboratoire de Biologie Médicale Synlab Provence Forcalquier, rue du Souvenir Français, 04300, Forcalquier, France.

Florence Fenollar (F)

IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13005, Marseille, France.
Institut de Recherche pour le Développement (IRD), Microbes Evolution Phylogeny and Infections (MEPHI), Aix-Marseille Université, 27 boulevard Jean Moulin, 13005, Marseille, France.
Institut de Recherche pour le Développement (IRD), Vecteurs-Infections Tropicales et Méditerranéennes (VITROME), Aix-Marseille Université, 27 boulevard Jean Moulin, 13005, Marseille, France.

Nouara Yahi (N)

Aix-Marseille Université, INSERM UMR S 1072, 51 boulevard Pierre Dramard, 13015, Marseille, France.

Jacques Fantini (J)

Aix-Marseille Université, INSERM UMR S 1072, 51 boulevard Pierre Dramard, 13015, Marseille, France.

Bernard La Scola (B)

IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13005, Marseille, France.
Institut de Recherche pour le Développement (IRD), Microbes Evolution Phylogeny and Infections (MEPHI), Aix-Marseille Université, 27 boulevard Jean Moulin, 13005, Marseille, France.
Assistance Publique-Hôpitaux de Marseille (AP-HM), 264 rue Saint-Pierre, 13005, Marseille, France.

Didier Raoult (D)

IHU Méditerranée Infection, 19-21 boulevard Jean Moulin, 13005, Marseille, France. didier.raoult@gmail.com.
Institut de Recherche pour le Développement (IRD), Microbes Evolution Phylogeny and Infections (MEPHI), Aix-Marseille Université, 27 boulevard Jean Moulin, 13005, Marseille, France. didier.raoult@gmail.com.

Articles similaires

Genome, Chloroplast Phylogeny Genetic Markers Base Composition High-Throughput Nucleotide Sequencing

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C

Classifications MeSH